/ Letters / Research for Alzheimer’s Disease

Research for Alzheimer’s Disease

July 24, 2020

To the Editor:

The Alzheimer’s Association International Conference® 2020 is happening virtually the week of July 27 with a renewed interest in advancing research for Alzheimer’s disease. In the midst of the COVID-19 pandemic, we’ve seen the importance of protecting our nation’s most vulnerable and how essential medical research is to the nation’s health and economic security.

As a family member for one of the more than 5 million Americans, including 120,000 Wisconsinites impacted by Alzheimer’s, I know the devastation of this disease.

My mother died at the age of 84 in a nursing home after several years of struggling with Alzheimer’s disease. My dad and I wanted to support this community so we got involved in the Walks to End Alzheimer’s, and I eventually joined the local Walk planning committee. In addition, in 2007 I contacted the Wisconsin Registry for Alzheimer’s Prevention (WRAP) and have participated in this UW-Madison family history research project since that time. I’ve also participated in several other Alzheimer’s research projects and feel it is vitally important for this research to continue!

In recent years Congress has made funding Alzheimer’s and dementia research a priority. In 2020, Alzheimer’s and other dementias will cost the nation $305 billion. We must increase funding for Alzheimer’s research and better support families currently affected. 

Please join me and the Alzheimer’s Association in encouraging Congressman Tom Tiffany to support a $354 million increase in Alzheimer’s research funding at the National Institutes of Health in fiscal year 2021. 


Neal Baudhuin

Rhinelander



Advertisement

 

Read This Next


{{ item.published_at | unix_to_date }}

{{ tag | uppercase}},

{{ item.title }}

{{ item.description | truncate(200) }}


See more letters »

Advertisement

 

Stay Connected to the Northwoods

Learn what a subscription to the Lakeland Times offers you:

Subscribe Today »